Neoadjuvant Zanzalintinib Plus Nivolumab in Patients With Locally Advanced and/or Inoperable Clear Cell Renal Cell Carcinoma With or Without Non-measurable Metastasis
for Locally Advanced Renal Cell Carcinoma
Drug: Nivolumab
3 locations incl. St Louis
Sponsor: Qian Qin
Sex: All·Age: 18+
Code: NCT06794229·Phase 2·Recruiting